Handelsbanken Fonder
KRON

Handelsbanken Fonder’s Kronos Bio KRON Stock Holding History

Handelsbanken Fonder’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,100
Closed -$73K – 1657
2022
Q1 		$73K Hold
10,100
– – ﹤0.01% 1692
2021
Q4 		$137K Hold
10,100
– – ﹤0.01% 1732
2021
Q3 		$212K Hold
10,100
– – ﹤0.01% 1647
2021
Q2 		$242K Buy
+10,100
New +$256K ﹤0.01% 1673

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Handelsbanken Fonder's KRON Position: Q2 2022 in Review

Handelsbanken Fonder sold out of Kronos Bio (KRON) in Q2 2022, closing a stake of 10,100 shares — an estimated $73K sold.

Handelsbanken Fonder first reported a position in KRON in Q2 2021 and held it in 4 quarters. The position peaked at $242K in Q2 2021. 93 funds tracked by Wall St. Rank hold KRON as of Q2 2022.

  • Handelsbanken Fonder reported no remaining Kronos Bio position as of Q2 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 10,100 Kronos Bio shares in Q2 2022, an estimated $73K.
  • Handelsbanken Fonder first reported a position in Kronos Bio in Q2 2021 and held it in 4 quarters.
  • Handelsbanken Fonder's Kronos Bio position peaked at $242K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2022.

Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.